| 1. |
肖永紅, 沈萍, 魏澤慶, 等.Mohnarin 2010年度全國細菌耐藥監測.中華醫院感染學雜志, 2011, 21:4896-4902.
|
| 2. |
Hotchkiss RS, Monneret G, Payen D.Sepsis-induced immunosuppression:from cellar dysfunction to immunotherapy.Nat Rev Immunol, 2013, 13:862-874.
|
| 3. |
Okazaki T, Honjo T.PD-1 and PD-1 ligands:from discovery to clinical application.Int Immunol, 2007, 19:813-824.
|
| 4. |
郭國寧, 謝諄怡, 陳永文.共抑制分子PD-1的研究進展.免疫學雜志, 2010, 26:639-642.
|
| 5. |
Powles T, Eder JP, Fine GD, et al.MPDL3280A(anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.Nature, 2014, 515:558-562.
|
| 6. |
Said EA, Dupuy FP, Trautmann L, et al.Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection.Nat Med, 2010, 16:452-459.
|
| 7. |
Huang X, Chen Y, Chung CS, et al.Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis.J Immunol, 2014, 192:1091-1099.
|
| 8. |
劉茜, 陸江陽, 王曉虹, 等.MODS小鼠脾臟樹突細胞PD-1、PD-L1的表達變化及其意義.解放軍醫學雜志, 2010, 35:17-19.
|
| 9. |
Zhang Y, Li J, Lou J, et, al.Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients.Crit Care, 2011, 15:R70.
|
| 10. |
Guignant C, Lepape A, Huang X, et al.Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.Crit Care, 2011, 15:R99.
|
| 11. |
Rittirsch D, Huber-Lang MS, Flierl MA, et al.Immunodesign of experimental sepsis by cecal ligation and puncture.Nat Protoc, 2009, 4:31-36.
|
| 12. |
Singleton KD, Wischmeyer PE.Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat.Eur Surg Res, 2003, 35:486-491.
|